Effect of dexmedetomidine and su fentanyl as adjuvants to Bupivacaine in Dynamic hip screw operations

Comparative study of intrathecal dexmedetomidine and su fentanyl as adjuvants to Bupivacaine in Dynamic hip screw operations

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017050220258N45

Enrollment

Registered

2017-08-04

Start date

2016-04-25

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fracture of hip. Fracture of neck of femur

Interventions

Intervention 1: Intervention group:We will inject 8 milligram Bupivacaine and 5 micro gram dexmedetomidine in first group ?. Intervention 2: Intervention group:We will inject 8 milligram Bupivacaine a

Treatment - Drugs

Intervention group:We will inject 8 milligram Bupivacaine and 5 micro gram dexmedetomidine in first group ?.

Intervention group:We will inject 8 milligram Bupivacaine and 2.5 micro gram sufentanyl in second group.?

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 20 to 60 years; Dynamic hip screw operations Exclusion criteria: allergy to dexmedetomidine and Bupivacaine ;breastfeeding women; hepatic and renal and cardiovascular disease; history of addiction; diabetes; long-term use of analgesics; taking Psychiatric Drug; anticoagulant; deformity of the spine; coagulation disorders; skin infection in site of spinal block

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Motor block. Timepoint: every 20 minute. Method of measurement: bromeg scale.;Pain. Timepoint: 1 and 2 and 6 and 12 and 24 hours after surgery. Method of measurement: Visual Analog Scale.;Use Apotel. Timepoint: in 24 hours after surgery. Method of measurement: milligram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hesamodin Modir

Arak University of Medical Sciences

modir@arakmu.a.c.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 19, 2026